WEE1 Inhibitor: Clinical Development

被引：0
|
作者：
Anthony Kong
Hisham Mehanna
机构：
[1] University of Birmingham,Institute of Head and Neck Studies (InHANSE)
[2] King’s College London,Comprehensive Cancer Centre
来源：
Current Oncology Reports | 2021年 / 23卷
关键词：
WEE1 inhibitor; Adavosertib; AZD1775; TP53 mutation; Biomarker; Clinical trials;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Inhibition of ATR Increases the Sensitivity to WEE1 Inhibitor in Biliary Tract Cancer
    Nam, Ah-Rong
    Jin, Mei-Hua
    Bang, Ju-Hee
    Oh, Kyoung-Seok
    Seo, Hye-Rim
    Oh, Do-Youn
    Bang, Yung-Jue
    CANCER RESEARCH AND TREATMENT, 2020, 52 (03): : 945 - 956
  • [22] Pharmacodynamic evidence for WEE1 target engagement in surrogate and tumor tissues from a phase I study of the WEE1 inhibitor ZN-c3
    Chalasani, P.
    Tolcher, A.
    Meric-Bernstam, F.
    Mamdani, H.
    de Jong, P. R.
    Anderes, K.
    Samatar, A. A.
    Sergeeva, M.
    Gazdoiu, M.
    Viana, M. R.
    Pultar, P.
    Voliotis, D.
    Donate, F.
    ANNALS OF ONCOLOGY, 2021, 32 : S593 - S593
  • [23] Sensitization of pancreatic cancer to chemoradiation by the Wee1 inhibitor AZD1775
    Kausar, Tasneem
    Parsels, Leslie A.
    Parsels, Joshua D.
    Karnak, David
    Davis, Mary A.
    Maybaum, Jonathan
    Lawrence, Theodore S.
    Morgan, Meredith A.
    CANCER RESEARCH, 2014, 74 (19)
  • [24] Identification of a novel Wee1 isoform
    Yu, YP
    Chen, B
    Chen, Z
    Fan, C
    Han, YF
    Zhang, J
    He, LZ
    Ingram, A
    Kapoor, A
    Wang, JH
    Tang, D
    BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION, 2005, 1729 (01): : 1 - 9
  • [25] Regulation of mitosis by Wee1 during syncytial stages of Drosophila development
    Homola, EM
    Campbell, SD
    MOLECULAR BIOLOGY OF THE CELL, 2002, 13 : 300A - 300A
  • [26] Targeting WEE1 Kinase in Cancer
    Matheson, Christopher J.
    Backos, Donald S.
    Reigan, Philip
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2016, 37 (10) : 872 - 881
  • [27] Overexpressed FOXM1 collaborates with MMB to increase WEE1 inhibitor sensitivity in NSCLC
    Tan, Jian
    Ma, Jingbo
    Zhang, Weiqiang
    Zhao, Jing
    Liu, Keqiang
    JOURNAL OF THORACIC DISEASE, 2023, 15 (06) : 3350 - 3358
  • [28] Preclinical in vivo evaluation of a novel treatment strategy combining a Wee1 inhibitor with radiotherapy
    Mason, K.
    Pickett, J.
    Ware, C.
    Hirai, H.
    Strack, P.
    Shumway, S. D.
    Ang, K.
    Buchholz, T. A.
    Milas, L.
    Buser, C. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [29] Phase II Study of the WEE1 Inhibitor Adavosertib in Recurrent Uterine Serous Carcinoma
    Liu, Joyce F.
    Xiong, Niya
    Campos, Susana M.
    Wright, Alexi A.
    Krasner, Carolyn
    Schumer, Susan
    Horowitz, Neil
    Veneris, Jennifer
    Tayob, Nabihah
    Morrissey, Stephanie
    West, Gabriela
    Quinn, Roxanne
    Matulonis, Ursula A.
    Konstantinopoulos, Panagiotis A.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (14) : 1531 - +
  • [30] Overexpression of PAXIP1 potentiates WEE1 inhibitor action in lung cancer cells
    Jhuraney, Ankita
    Woods, Nicholas T.
    Kinose, Fumi
    Cress, Douglas W.
    Gray, Jhanelle E.
    Haura, Eric B.
    Rix, Uwe
    Monteiro, Alvaro N.
    CANCER RESEARCH, 2014, 74 (19)
12345